Caryn Gordon McDowell's Net Worth
$3.23 Million
Who is Caryn Gordon McDowell?
Caryn Gordon McDowell has an estimated net worth of $3.23 Million. This is based on reported shares across multiple companies, which include Revance Therapeutics, Inc., CYTOKINETICS INC, and Cortexyme, Inc..
SEC CIK
Caryn Gordon McDowell's CIK is 0001674232
Past Insider Trading and Trends
2017 was Caryn Gordon McDowell's most active year for acquiring shares with 15 total transactions. Caryn Gordon McDowell's most active month to acquire stocks was the month of December. 2017 was Caryn Gordon McDowell's most active year for disposing of shares, totalling 73 transactions. Caryn Gordon McDowell's most active month to dispose stocks was the month of August. 2017 saw Caryn Gordon McDowell paying a total of $212,733.19 for 62,707 shares, this is the most they've acquired in one year. In 2017 Caryn Gordon McDowell cashed out on 71,727 shares for a total of $550,126.57, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Revance Therapeutics, Inc. (RVNC) Snapshot price: $5.375
SVP, GC & Secretary
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.55% | -864.00 |
$25.33 | -$21,885.12 | 23.45K |
Feb 15
| |||
Form 4
| +1.60% | 382 |
$10.82 | $4,133.24 | 24.32K |
Dec 31
| |||
Form 4
| +4.36% | 1K |
$11.02 | $11,024.50 | 23.93K |
Jun 28
| |||
Form 4
| -5.69% | -1.38K |
$10.86 | -$15,019.38 | 22.93K |
Jun 15
| |||
Form 4
| +44.60% | 7.5K |
—
|
—
| 24.32K |
Jan 24
| |||
Form 4
| +5.11% | 818 |
$17.11 | $13,996.39 | 16.82K |
Dec 31
| |||
Form 4
|
∞
| 16K |
—
|
—
| 16K |
May 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CYTOKINETICS INC (CYTK) Snapshot price: $77.73
GC & Chief Compliance Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +116.99% | 17.55K |
$7.75 | -$18,983.00 | 32.55K |
Feb 27 - Feb 28
| |||
Form 4
|
—
|
0
|
$7.77 | -$6,686.97 | 15K |
Scheduled
|
Jan 16
| ||
Form 4
| -16.22% | -2.90K |
$9.74 | -$46,283.65 | 15K |
Scheduled
|
Nov 2
| ||
Form 4
| -8.70% | -1.60K |
$11.00 | -$128,810.21 | 16.77K |
Scheduled
|
Oct 6
| ||
Form 4
| -0.54% | -100.00 |
$15.00 | -$1,500.00 | 18.37K |
Scheduled
|
Sep 6
| ||
Form 4
| +0.54% | 100 |
$10.55 | -$81,342.58 | 18.47K |
Scheduled
|
Sep 6
| ||
Form 4
| -8.97% | -1.81K |
$9.49 | -$79,471.94 | 18.37K |
Scheduled
|
Aug 8
| ||
Form 4
| +418.88% | 15K |
—
| $15.00 | 18.58K |
Feb 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cortexyme, Inc. (QNCX) Snapshot price: $1.21
Chief Legal & Adm. Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -12.50% | -17.50K |
$2.86 | -$50,106.00 | 122.5K |
Scheduled
|
Jun 6
| ||
Form 4
|
∞
| 140K |
—
|
—
| 140K |
Mar 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||